BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 12726819)

  • 1. Mutation in a protein kinase C phosphorylation site of the 5-HT1A receptor preferentially attenuates Ca2+ responses to partial as opposed to higher-efficacy 5-HT1A agonists.
    Wurch T; Colpaert FC; Pauwels PJ
    Neuropharmacology; 2003 Jun; 44(7):873-81. PubMed ID: 12726819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S 14506: novel receptor coupling at 5-HT(1A) receptors.
    Milligan G; Kellett E; Dacquet C; Dubreuil V; Jacoby E; Millan MJ; Lavielle G; Spedding M
    Neuropharmacology; 2001 Mar; 40(3):334-44. PubMed ID: 11166326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonist activity of meta-chlorophenylpiperazine and partial agonist activity of 8-OH-DPAT at the 5-HT(7) receptor.
    Wood M; Chaubey M; Atkinson P; Thomas DR
    Eur J Pharmacol; 2000 May; 396(1):1-8. PubMed ID: 10822046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Memory of an operant response and of depressed mood retained in activation states of 5-HT(1A) receptors: evidence from rodent models.
    Colpaert FC; Bruins Slot LA; Koek W; Dupuis DS
    Behav Brain Res; 2000 Dec; 117(1-2):41-51. PubMed ID: 11099756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of 5-HT(1A) receptor-mediated Ca(2+) responses by co-expression with various recombinant G(alpha) proteins in CHO-K1 cells.
    Wurch T; Pauwels PJ
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Aug; 368(2):99-105. PubMed ID: 12879209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of 5-HT(1A) receptor activation by its interaction with wild-type and mutant g(alphai3) proteins.
    Dupuis DS; Wurch T; Tardif S; Colpaert FC; Pauwels PJ
    Neuropharmacology; 2001; 40(1):36-47. PubMed ID: 11077069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Labelling of recombinant human and native rat serotonin 5-HT1A receptors by a novel, selective radioligand, [3H]-S 15535: definition of its binding profile using agonists, antagonists and inverse agonists.
    Newman-Tancredi A; Verrièle L; Chaput C; Millan MJ
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):205-17. PubMed ID: 9550290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential modulation by GTPgammaS of agonist and inverse agonist binding to h5-HT(1A) receptors revealed by [3H]-WAY100,635.
    Newman-Tancredi A; Verrièle L; Millan MJ
    Br J Pharmacol; 2001 Jan; 132(2):518-24. PubMed ID: 11159702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of the avidity of ternary complexes containing the human 5-HT(1A) receptor by mutation of a receptor contact site on the interacting G protein alpha subunit.
    Welsby PJ; Carr IC; Wilkinson G; Milligan G
    Br J Pharmacol; 2002 Oct; 137(3):345-52. PubMed ID: 12237254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1A receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa cells.
    Pauwels PJ; Van Gompel P; Leysen JE
    Biochem Pharmacol; 1993 Jan; 45(2):375-83. PubMed ID: 8382063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effects of serotonergic agonists with varying efficacy at the 5-HT(1A) receptor on core body temperature: modification by the selective 5-HT(1A) receptor antagonist WAY 100635.
    Cryan JF; Kelliher P; Kelly JP; Leonard BE
    J Psychopharmacol; 1999; 13(3):278-83. PubMed ID: 10512084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons.
    Mos J; Van Hest A; Van Drimmelen M; Herremans AH; Olivier B
    Eur J Pharmacol; 1997 May; 325(2-3):145-53. PubMed ID: 9163561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant 5-hydroxytryptamine 1A receptor D116A is a receptor activated solely by synthetic ligands with a rich pharmacology.
    Cussac D; Palmier C; Finana F; De Vries L; Tardif S; Léger C; Bernois S; Heusler P
    J Pharmacol Exp Ther; 2009 Oct; 331(1):222-33. PubMed ID: 19605522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S 15535 and WAY 100,635 antagonise 5-HT-stimulated [35S]GTP gamma S binding at cloned human 5-HT1A receptors.
    Newman-Tancredi A; Chaput C; Verrièle L; Millan MJ
    Eur J Pharmacol; 1996 Jun; 307(1):107-11. PubMed ID: 8831111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Hydroxytryptamine(1A) receptor-stimulated [(35)S]GTPgammaS binding in rat brain: absence of regional differences in coupling efficiency.
    Meller E; Li H; Carr KD; Hiller JM
    J Pharmacol Exp Ther; 2000 Feb; 292(2):684-91. PubMed ID: 10640306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The putative <> 5-HT(1A) receptor antagonist, WAY 100635, has inverse agonist properties at cloned human 5-HT(1A) receptors.
    Cosi C; Koek W
    Eur J Pharmacol; 2000 Jul; 401(1):9-15. PubMed ID: 10915831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nad-299 antagonises 5-HT-stimulated and spiperone-inhibited [35S]GTPgammaS binding in cloned 5-HT1A receptors.
    Jerning E; Rosqvist S; Mohell N
    J Recept Signal Transduct Res; 2002; 22(1-4):483-95. PubMed ID: 12503636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-HT1A receptors and the tail-flick response. VI. Intrinsic alpha 1A-adrenoceptor antagonist properties can mask the actions of 5-HT1A receptor agonists in the spontaneous tail-flick paradigm.
    Millan MJ; Rivet JM; Gobert A; Canton H; Veiga S; Bervoets K
    J Pharmacol Exp Ther; 1994 Apr; 269(1):121-31. PubMed ID: 7909555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agonist properties of pindolol at h5-HT1A receptors coupled to mitogen-activated protein kinase.
    Millan MJ; Newman-Tancredi A; Duqueyroix D; Cussac D
    Eur J Pharmacol; 2001 Jul; 424(1):13-7. PubMed ID: 11470255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of 5-HT(1A) receptors in hippocampal and cortical homogenates.
    Alper RH; Nelson DL
    Eur J Pharmacol; 2000 Feb; 390(1-2):67-73. PubMed ID: 10708708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.